Fosfomycin-Ca(経口剤)の副鼻腔炎に対する治療成績
スポンサーリンク
概要
- 論文の詳細を見る
Fosfomycin FOM, 2g/day, was administered orally to 25 patients of acute or chronic sinusitis paranasalis and acute exacerbation. The following results were obtained from clinical and laboratory examinations.1) Eleven patients were evaluated at the fourteenth day, according to the unified criteria. According to the physicians' evaluation, excellent results were seen in 3 patients, good results in 8. According to the unified criteria for judgment, excellent results were seen in 7 patients, good in 3 and moderate in 1 with respect to improvement in subjective and objective symptoms, and in terms of X-ray findings, an excellent result was seen in 1, good in 5, moderate in 2 and poor in 3. Improvement in X-ray findings was inferior to that of subjective and objective symptoms. Microorganisms isolated disappeared in 9 but different microorganisms appeared in 2 patients.2) Fourteen patients were evaluated at seventh day. According to the physicians' evaluation, excellent results were obtained in 5, good in 1, moderate in 6 and poor in 2. According to the unified criteria for judgment, excellent results were found in 4, good in 4, moderate in 4 and poor in 2. Eight cases were evaluated for microorganisms. Isolated microorganisms disappeared completely in 6, and different microorganisms appeared in 2. The clinical results of these 14 patients were inferior to those of the patients who received administration for 14 days.3. The MICs against Haemohilus influenzae, Streptococcus pneumoniae and Staphylococcus aureus were in the ranges of 1.56-6.25, 3.13-6.25 and 1.56-12.5μg/ml, respectively. And the MICs against Streptococcus pyogenes and Klebsiella pneumoniae were 3.13, 25μg/ml, respectively. Fosfomycin was effective in four organisms which caused sinusitis paranasalis, except Klebsiella pneumoniae.4. The peak values of FOM in the serum and tissue were 6.3μg/ml and 4.1μg/ml, 2 hours and 15 minutes after administration of 1g of FOM.5. As to the side effects of FOM, diarrhea was noted in 6 of the 24 patients. Diarrhea started 2 to 5 days after administration. Regarding laboratory findings, slight elevation of s-GPT was observed in 2 of the 11 patients.
- 耳鼻咽喉科臨床学会の論文
著者
関連論文
- Fosfomycin-Ca(経口剤)の副鼻腔炎に対する治療成績
- 頭部外傷性めまいの検討 ("めまい"の臨床)
- Downbeat nystagmusを呈した扁平頭蓋底,頭蓋底陥入症,Klippel-Feil症候群の合併例
- 喉頭癌と喫煙の関係調査
- 鼻副鼻腔原発と考えられる悪性リンパ腫4例の検討 (リンパ節疾患を主とした血液疾患) -- (悪性リンパ腫)
- Bleomycin(BLM)による肺線維症症例の検討 (肺疾患)
- 扁桃癌患者に急性び漫性化膿性腹膜炎を合併した1症例
- 平衡機能検査の合理化について (めまい疾患)
- 19. 先天性喘鳴の7例について(第481回千葉医学会例会,第67回日本小児科学会千葉地方会総会)
- コンピュ-タ-回転検査の臨床的検討
- ヒメガマ花粉症
- Fosfomycin-Ca(経口剤)の副鼻腔炎に対する治療成績
- 睡眠時無呼吸症の閉塞部位診断
- 上顎癌術後の再建法-嶢骨付前腕皮弁の試み
- 巨大な茎状突起過長症の一例
- 高度の不整脈を伴った睡眠時無呼吸症候群の一例
- 舌根扁桃切除で治癒した難治性喉頭蓋炎
- 左扁桃上極部に生じた扁桃結石の一例